The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Role of Anti-Hepatitis C Virus (HCV) Treatment in HCV-Related, Low-Grade, B-Cell, Non-Hodgkin's Lymphoma: A Multicenter Italian Experience
Abstract
Purpose: Hepatitis C virus (HCV) is endemic in some areas of Northwestern Europe and the United States. HCV has been shown to play a role in the development of both hepatocellular carcinoma and B-cell non-Hodgkin's lymphoma (B-NHL). The biologic mechanisms underlying the lymphomagenic activity of the virus so far are under investigation. In this study, the role of antiviral (anti-HCV) treatment in B-NHL associated with HCV infection is evaluated. Patients and Methods: Thirteen patients with histologically proven low-grade B-NHL characterized by an indolent course (ie, doubling time no less than 1 year, no bulky disease) and carrying HCV infection were enrolled on the study. All patients underwent antiviral treatment alone with pegilated interferon and ribavirin. Response assessment took place at 6 and 12 months. Results: Of the twelve assessable patients, seven (58%) achieved complete response and two (16%) partial hematologic response at 14.1 ± 9.7 months (range, 2 to 24 months, median follow-up, 14 months), while two had stable disease with only one patient experiencing progression of disease. Hematologic responses (complete and partial, 75%) were highly significantly associated to clearance or decrease in serum HCV viral load following treatment (P = .005). Virologic response was more likely to be seen in HCV genotype 2 (P = .035), while hematologic response did not correlate with the viral genotype. Treatment-related toxicity did not cause discontinuation of therapy in all but two patients, one of whom, however, achieved complete response. Conclusion: This experience strongly provides a role for antiviral treatment in patients affected by HCV-related, low-grade, B-cell NHL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I., Connors, J. M., Lister, T. A., Vose, J., Grillo-López, A., Hagenbeek, A., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1244 · Cited by 3,486
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
WOTHERSPOON, A. (1991) · The Lancet · doi:10.1016/0140-6736(91)92035-z · Cited by 1,866
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Zeuzem, S., Feinman, S. V., Rasenack, J., Heathcote, E. J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Diago, M., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432301 · Cited by 1,220
Hermine, O., Lefrère, F., Bronowicki, J.-P., Mariette, X., Jondeau, K., Eclache-Saudreau, V., Delmas, B., Valensi, F., Cacoub, P., Brechot, C., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013376 · Cited by 807
Harris, N. L. (1995) · Current Diagnostic Pathology · doi:10.1016/s0968-6053(00)80051-4 · Cited by 527
Gribben, J., Freedman, A., Woo, S., Blake, K., Shu, R., Freeman, G., Longtine, J., Pinkus, G., & Nadler, L. (1991) · Blood · doi:10.1182/blood.v78.12.3275.3275 · Cited by 330
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study
Mele, A., Pulsoni, A., Bianco, E., Musto, P., Szklo, A., Sanpaolo, M. G., Iannitto, E., De Renzo, A., Martino, B., Liso, V., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3230 · Cited by 302
HCV-associated liver cancer without cirrhosis
De Mitri, M. S., Pisi, E., Poussin, K., Paterlini, P., Bréchot, C., Baccarini, P., D'Errico, A., Grigiani, W., Alberti, A., Pontisso, P., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90400-x · Cited by 294
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia
Ferri, C., Monti, M., La Civita, L., Longombardo, G., Greco, F., Pasero, G., Gentilini, P., Bombardieri, S., & Zignego, A. (1993) · Blood · doi:10.1182/blood.v82.12.3701.bloodjournal82123701 · Cited by 291
Solal-Celigny, P., Lepage, E., Brousse, N., Reyes, F., Haioun, C., Leporrier, M., Peuchmaur, M., Bosly, A., Parlier, Y., Brice, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311253292203 · Cited by 268
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia
Ferri, C., Monti, M., La Civita, L., Longombardo, G., Greco, F., Pasero, G., Gentilini, P., Bombardieri, S., & Zignego, A. (1993) · Blood · doi:10.1182/blood.v82.12.3701.3701 · Cited by 255
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K.-I., Sata, M., Kohara, M., & Yoshimura, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012127 · Cited by 236
Chan, C. H., Hadlock, K. G., Foung, S. K. H., & Levy, S. (2001) · Blood · doi:10.1182/blood.v97.4.1023 · Cited by 191
Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma
Smalley, R. V., Andersen, J. W., Hawkins, M. J., Bhide, V., O'Connell, M. J., Oken, M. M., & Borden, E. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211053271902 · Cited by 173
(2015) · Diagnostic Pathology: Infectious Diseases · doi:10.1016/b978-0-323-37677-8.50024-3 · Cited by 172
Baker, A. (1993) · Hepatology · doi:10.1016/0270-9139(93)90374-v · Cited by 159
Marasca, R., Vaccari, P., Luppi, M., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61691-4 · Cited by 154
Self-citationHarris, N. L. (1997) · Annals of Oncology · doi:10.1093/annonc/8.suppl_2.s11 · Cited by 41
Cited by
Armitage, J. O., Gascoyne, R. D., Lunning, M. A., & Cavalli, F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32407-2 · Cited by 1,176
Suarez, F. (2006) · Blood · doi:10.1182/blood-2005-09-3679 · Cited by 457
De Sanjose, S., Benavente, Y., Vajdic, C. M., Engels, E. A., Morton, L. M., Bracci, P. M., Spinelli, J. J., Zheng, T., Zhang, Y., Franceschi, S., et al. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.011 · Cited by 338
Extrahepatic manifestations of chronic hepatitis C virus infection
Cacoub, P., Gragnani, L., Comarmond, C., & Zignego, A. L. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.10.005 · Cited by 293
Extrahepatic manifestations of chronic hepatitis C virus infection
Cacoub, P., Comarmond, C., Domont, F., Savey, L., Desbois, A. C., & Saadoun, D. (2016) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936115585942 · Cited by 291
Metadata
- Authors
- Vallisa, D., Bernuzzi, P., Arcaini, L., Sacchi, S., Callea, V., Marasca, R., Lazzaro, A., Trabacchi, E., Anselmi, E., Arcari, A. L., Moroni, C., Bertè, R., Lazzarino, M., & Cavanna, L.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-01-20
- Volume
- 23
- Issue
- 3
- Pages
- 468-473
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2150990886
- Cited by
- 263
- References
- 23
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.